J. Scott Garland - 07 Jan 2026 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role: Director
Signature: /s/ Ben Hohl, by power of attorney
Issuer symbol: ELVN
Transactions as of: 07 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2026, 18:10:31 UTC
Previous filing: 07 Nov 2025
Next filing: 21 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Garland J. Scott	Director	C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER	/s/ Ben Hohl, by power of attorney	09 Jan 2026	0001533228

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELVN	Stock Option (right to buy)	Award	$0	+59,372		$0.000000	59,372	07 Jan 2026	Common Stock	59,372	$15.47	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/36th of the shares subject to the option will vest on February 7, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.